SUMMARY
Lateral thoracotomy wounds are amongst the most painful [1] , but local anaesthetic in the intercostal space has been shown to relieve pain after thoracotomy effectively [2] . Problems associated with percutaneous intercostal nerve block include intravascular injection, puncture of the parietal pleura and a significant failure rate [3, 4] . The risks are increased if repeated injections are used, rather than a catheter technique. Bupivacaine delivered via catheters placed in the intercostal space during surgery has been described recently as a means of providing analgesia after thoracotomy [5] . Our study was designed to assess the analgesic efficacy after thoracotomy of continuous intercostal nerve block compared with placebo.
PATIENTS AND METHODS
After obtaining local Ethics Committee approval and informed written consent, we studied patients admitted for elective surgery through a single lateral thoracotomy incision. Patients were instructed how to use a patient-controlled analgesia device (Graseby 2000, Graseby Medical Ltd, Watford, U.K.). Anaesthetic technique was standardized. Benzodiazepine premedication was provided and anaesthesia was induced with etomidate 0.3 mg kg" 1 . Anaesthesia was maintained with 0.5-1.5% enflurane and 50% nitrous oxide in oxygen, supplemented with morphine 10 mg i.v. Vecuronium 0.1 mg kg" 1 i.v. with further increments of 0.03 mg kg" 1 as required was used to facilitate mechanical ventilation of the lungs. Neuromuscular block was antagonized subsequently with neostigmine 2.5 mg and glycopyrronium 0.5 mg i.v. Immediately before closure of the chest, two 16-gauge extradural catheters (Portex Ltd, Hythe, U.K.) were placed under direct vision, in the intercostal spaces immediately above and below the wound, by feeding the catheters posteriorly from the wound edges, superficial to the parietal pleura, and bringing the catheters out through the chest wall using the Tuohy needles.
Patients were allocated randomly to group A or group B using sealed envelopes. The trial was designed as a crossover study with patients receiving either 0.25 % bupivacaine for the first 24 h and saline for the second (group A), or saline for the first 24 h, followed by bupivacaine (group B). The solutions were infused continuously at a rate of 5 ml h" 1 through each of the two intercostal catheters. Each catheter was primed with 10 ml of the appropriate solution. Both patient and investigator were blind to the nature of the solution.
On regaining consciousness, patients were given further increments of morphine 1-2 mg i.v. until they were comfortable and able to operate the patient controlled analgesia device (PCA). The PGA device was programmed to deliver morphine 1 mg i.v., with a lock-out duration of 3 min.
Morphine consumption from the PCA was recorded hourly throughout the 48 h of the study period. The patients performed visual analogue scores (VAS) of pain on a 100-mm horizontal line at 1, 3, 6, 24 and 48 h after operation. At 4-h intervals, nursing staff graded and recorded the level of pain, sedation and nausea using the scoring systems detailed in table I.
Lopamidol 10 ml (Niopam 300) was injected through the intercostal catheters, before routine postoperative radiography in the recovery room, to confirm correct placement of the catheters and to outline the likely route of spread of local anaesthetic solution.
Statistical significance was tested using one-way analysis of variance for morphine consumption data. The Kruskal-Wallis test was used for VAS data and chi-square test for scores assessed by nursing staff. Statistical significance was accepted when P < 0.05.
RESULTS
Twenty-two patients entered the study. One patient required mechanical ventilation after operation and the PCA device suffered malfunction during another case. Complete data were available therefore for 20 patients. Details of the patients' characteristics and of surgical procedure are given in table II.
Patients consumed less morphine while receiving intercostal bupivacaine than while receiving intercostal saline (table III) . The 24-h morphine requirements of group A patients decreased by a mean (95% confidence limits) of 3.90 (-8.4, 16.2) mg for day 2 (saline) compared with day 1 (bupivacaine). The 24-h morphine requirements of group B patients decreased by a mean of 34.10 (13.0, 55.2) mg for day 2 (bupivacaine) compared with day 1 (saline) (P = 0.01). Patients recorded smaller visual analogue scores of pain while receiving bupivacaine (table IV) .
Scores assessed by nursing staff for pain, sedation and nausea did not differ in patients receiving either bupivacaine or saline ( fig. 1) .
Radiography demonstrated spread of contrast medium along the intercostal space and the ipsilateral paravertebral space (fig. 2 ).
BRITISH JOURNAL OF ANAESTHESIA DISCUSSION Administration of bupivacaine by the intercostal route reduced the requirement for morphine after thoracotomy. Individual requirements for postoperative analgesia vary greatly, but the crossover design of this study allowed each patient to act as his or her own control. Analgesic requirements would be expected to decrease over the 48-h period of the study, but this should affect both groups A and B similarly.
Patients recorded smaller visual analogue scores of pain while receiving bupivacaine. This suggests that patients were more comfortable with intercostal bupivacaine and self-administered morphine than with self-administered morphine alone.
There were no differences in the nursing assessment of degree of pain, sedation and nausea between patients when receiving bupivacaine or placebo. This may reflect the insensitive nature of the scoring systems used.
The radiographic demonstration of contrast medium in the paravertebral space suggests that paravertebral block contributed to the efficacy of this technique. It has been demonstrated previously that intercostal injections spread via the paravertebral space [3, 4, 6] . However, it should not be assumed that an intercostal injection of contrast medium and an intercostal infusion of bupivacaine behave similarly. Morphine consumption by patients during bupivacaine infusion was greater than would be expected (mean 29 mg, 95 % CL 22, 37 mg) if paravertebral block was significant. In a study of bupivacaine infused into the paravertebral space after thoracotomy, the mean requirement for papaveretum was 14 mg in the first 48 h [7] . Sources of pain after thoracotomy potentially covered by paravertebral but not by intercostal block include the ribs and costochondral joints, viscera and the chest drain site [8] .
No patient in this study required treatment for hypotension or catheterization for urinary retention, which compares favourably with extradural analgesia [9] . The technique described here had the further attraction that placement of the catheters was performed under direct vision, increasing the incidence of correct positioning whilst also reducing the risks of injury to the lung and of intravascular placement.
Although the intercostal space is highly vascular, with rapid absorption of local anaesthetics [10] , the dose of bupivacaine required for this technique (25 mg hr 1 ) is well below the recommended safety limit of 2 mg kg" 1 in any 4-h period. Chan and colleagues [5] injected 0.5 % bupivacaine 10 ml with adrenaline 6-hourly through intercostal catheters. They studied six patients for 48 h after thoracotomy and found plasma concentrations of bupivacaine to be less than 4 ug ml" 1 . We conclude that a continuous intercostal infusion of bupivacaine is associated with a low incidence of complications, and provides an effective adjunct to systemic opioids in the relief of pain after thoracotomy.
